Areas of Focus
Categories
China
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
5,032
By Status
RECRUITING: 1TERMINATED: 1COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Today
Hover over trial bars to see details
Recent Trials
NCT04972604Lead Sponsor
CureDuchenne Link®: A Resource for Research
N/ARecruiting
5,000 participants
Started: Jul 9, 2021 · Completed: Jul 9, 2031
NCT02900248Lead Sponsor
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
N/ATerminated
23 participants
Started: Oct 2, 2017 · Completed: Mar 29, 2019
NCT02195999Collaborator
Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy
N/ACompleted
9 participants
Started: Dec 31, 2013 · Completed: Mar 6, 2019
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...